Antenatal Screening for Toxoplasmosis and Rubella in Saudi Arabia: Assessing the Need for Screening

References

• Milne G, Webster JP, Walker M. Toxoplasma gondii: an underestimated threat? Trends Parasitol. 2020;36(12):959–969. doi:10.1016/j.pt.2020.08.005
   PubMed Web of Science ®Google Scholar
• Robinson JL, Lee BE, Preiksaitis JK, Plitt S, Tipples GA. Prevention of congenital rubella syndrome—what makes sense in 2006? Epidemiol Rev. 2006;28(1):81–87. doi:10.1093/epirev/mxj007
   PubMedGoogle Scholar
• Martin S. Congenital toxoplasmosis. Neonatal Netw. 2001;20(4):23–30. doi:10.1891/0730-0832.20.4.23
   PubMedGoogle Scholar
• Havelaar A, Kemmeren J, Kortbeek L. Disease burden of congenital toxoplasmosis. Clin Infect Dis. 2007;44(11):1467–1474. doi:10.1086/517511
   PubMed Web of Science ®Google Scholar
• Gyorkos TW, Tannenbaum TN, Abrahamowicz M, Delage G, Carsley J, Marchand S. Evaluation of rubella screening in pregnant women. CMAJ. 1998;159(9):1091–1097.
   PubMed Web of Science ®Google Scholar
• Lim GH, Harris T, Desai S, et al. Rubella immunity among prenatal women in Ontario, 2006–2010. BMC Infect Dis. 2013;13:1–9. doi:10.1186/1471-2334-13-362
   PubMed Web of Science ®Google Scholar
• Lange A, Thyrian J, Wetzka S, et al. The impact of socioeconomic factors on the efficiency of voluntary toxoplasmosis screening during pregnancy: a population-based study. BMC Pregnancy Childbirth. 2016;16(1):1–9. doi:10.1186/s12884-016-0966-0
   PubMedGoogle Scholar
• Asiri AYS, Alsawa ITA, Anas MOF, et al. Cost-effectiveness analysis of serological prenatal screening for pregnant women in King Abdulaziz University Hospital: a single-center retrospective study. 2020.
   Google Scholar
• Baqer NN, Saheb EJ, Ahmed NS, Alhadad NAA. The association of IL-3, IL-17A, and IL 27 serum levels with susceptibility to toxoplasmosis in recurrent abortion of Iraqi women. Exp Parasitol. 2022;234:108217. doi:10.1016/j.exppara.2022.108217
   PubMed Web of Science ®Google Scholar
• Almalki SSR, Ahmed WA, Elhaj YHA, et al. Demographical and clinical features of suspected cases of rotavirus gastroenteritis at Al-Baha region, Saudi Arabia. Saudi J Health Sci. 2022;11(1):43–47. doi:10.4103/sjhs.sjhs_38_22
   Google Scholar
• Hazazi AA, Alhaj YH, Ahmed WA, et al. Seroprevalence of TORCH agents in women with spontaneous miscarriage in Jizan, Saudi Arabia. Egypt Acad J Biol Sci. 2023;15(2):79–90. doi:10.21608/eajbsc.2023.309933
   Google Scholar
• Damar Çakırca T, İN C, Deniz M, Torun A, Akçabay Ç, Güzelçiçek A. Toxoplasmosis: a timeless challenge for pregnancy. Trop Med Infect Dis. 2023;8(1):63. doi:10.3390/tropicalmed8010063
   PubMedGoogle Scholar
• Dubey J, Murata F, Cerqueira-Cézar C, Kwok O, Villena I. Congenital toxoplasmosis in humans: an update of worldwide rate of congenital infections. Parasitology. 2021;148(12):1406–1416. doi:10.1017/S0031182021001013
   PubMed Web of Science ®Google Scholar
• Mandelbrot L. Congenital toxoplasmosis: what is the evidence for chemoprophylaxis to prevent fetal infection? Prenat Diagn. 2020;40(13):1693–1702. doi:10.1002/pd.5758
   PubMed Web of Science ®Google Scholar
• Boubaker K, Raeber P, Vaudaux B, et al. Toxoplasmosis during pregnancy and infancy. A new approach for Switzerland. Swiss Med Wkly. 2008;138(49–50):1–8. doi:10.4414/SMW.2008.w30271
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control Prevention. Revised ACIP recommendation for avoiding pregnancy after receiving a rubella-containing vaccine. MMWR Morb Mortal Wkly Rep. 2001;50(49):1117.
   PubMedGoogle Scholar
• Donadono V, Saccone G, Maruotti GM, et al. Incidence of toxoplasmosis in pregnancy in Campania: a population-based study on screening, treatment, and outcome. Eur J Obstet Gynecol Reprod Biol. 2019;240:316–321. doi:10.1016/j.ejogrb.2019.07.033
   PubMed Web of Science ®Google Scholar
• Mohamed K. Toxoplasmosis in humans and animals in Saudi Arabia: a systematic review. J Infect Dev Ctries. 2020;14(08):800–811. doi:10.3855/jidc.12648
   PubMedGoogle Scholar
• Lago EG, Neto EC, Melamed J, et al. Congenital toxoplasmosis: late pregnancy infections detected by neonatal screening and maternal serological testing at delivery. Paediatric Perinatal Epidemiol. 2007;21(6):525–531. doi:10.1111/j.1365-3016.2007.00869.x
   PubMed Web of Science ®Google Scholar
• Tanimura K, Yamada H. Maternal and neonatal screening methods for congenital cytomegalovirus infection. J Obstetrics Gynaecol Res. 2019;45(3):514–521. doi:10.1111/jog.13889
   PubMed Web of Science ®Google Scholar
• Cutts F, Vynnycky E. Modelling the incidence of congenital rubella syndrome in developing countries. Int J Epidemiol. 1999;28(6):1176–1184. doi:10.1093/ije/28.6.1176
   PubMed Web of Science ®Google Scholar
• Mawson AR, Croft AM. Rubella virus infection, the congenital rubella syndrome, and the link to autism. Int J Environ Res Public Health. 2019;16(19):3543. doi:10.3390/ijerph16193543
   PubMed Web of Science ®Google Scholar
• Shanmugasundaram D, Awasthi S, Dwibedi B, et al. Burden of congenital rubella syndrome (CRS) in India based on data from cross-sectional serosurveys, 2017 and 2019–20. PLoS Negl Trop Dis. 2021;15(7):e0009608. doi:10.1371/journal.pntd.0009608
   PubMed Web of Science ®Google Scholar
• Su Q, Feng Z, Hao L, et al. Assessing the burden of congenital rubella syndrome in China and evaluating mitigation strategies: a metapopulation modelling study. Lancet Infect Dis. 2021;21(7):1004–1013. doi:10.1016/S1473-3099(20)30475-8
   PubMed Web of Science ®Google Scholar
• Alsibiani SA. Rubella immunity among pregnant women in Jeddah, Western region of Saudi Arabia. Obstet Gynecol Int. 2014;2014:1–6. doi:10.1155/2014/659838
   Google Scholar
• Nori W, Ali AI. Toxoplasmosis, a zoonotic infection; A critical and updated analysis: a Review Article. Iraqi J Vet Sci. 2021;35(Supplement I–III):95–99. doi:10.33899/ijvs.2021.131607.1980
   Google Scholar
• Varella IS, Wagner MB, Darela AC, Nunes LM, Muller R. Seroprevalence of toxoplasmosis in pregnant women. J Pediatr. 2003;79(1):69–74.
   Google Scholar
• Adeniyi OT, Adekola SS, Oladipo OM. Seroprevalence and risk factors associated with Toxoplasma gondii infection among pregnant women in Ile Ife, Southwestern Nigeria; 2023.
   Google Scholar
• Gurlek B, Colak S. Antenatal toxoplasma gondii, rubella and cytomegalovirus infection screening among pregnant women attending tertiary university hospital. Obstet Gynaecol Reprod Med. 2019;25(2):74–80. doi:10.21613/GORM.2019.903
   Google Scholar
• Campos VS, Calaza KC, Adesse D. Implications of TORCH diseases in retinal development—special focus on congenital toxoplasmosis. Front Cell Infect Microbiol. 2020;10:577. doi:10.3389/fcimb.2020.585727
   Web of Science ®Google Scholar
• McAuley JB. Congenital toxoplasmosis. J Pediatric Infect Dis Soc. 2014;3(suppl_1):S30–S35. doi:10.1093/jpids/piu077
   PubMedGoogle Scholar
• Garweg JG, Kieffer F, Mandelbrot L, Peyron F, Wallon M. Long-term outcomes in children with congenital toxoplasmosis—a systematic review. Pathogens. 2022;11(10):1187. doi:10.3390/pathogens11101187
   PubMed Web of Science ®Google Scholar
• Gargaté MJ, Ferreira I, Vilares A, et al. Toxoplasma gondii seroprevalence in the Portuguese population: comparison of three cross-sectional studies spanning three decades. BMJ open. 2016;6(10):e011648. doi:10.1136/bmjopen-2016-011648
   PubMed Web of Science ®Google Scholar
• Shwab EK, Zhu X-Q, Majumdar D, et al. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014;141(4):453–461. doi:10.1017/S0031182013001844
   PubMed Web of Science ®Google Scholar
• Schmidt DR, Hogh B, Andersen O, Fuchs J, Fledelius H, Petersen E. The national neonatal screening programme for congenital toxoplasmosis in Denmark: results from the initial four years, 1999–2002. Arch Dis Child. 2006;91(8):661–665. doi:10.1136/adc.2004.066514
   PubMed Web of Science ®Google Scholar
• Jones JL, Lopez A, Wilson M, Schulkin J, Gibbs R. Congenital toxoplasmosis: a review. Obstet Gynecol Surv. 2001;56(5):296–305. doi:10.1097/00006254-200105000-00025
   PubMed Web of Science ®Google Scholar
• De Paschale M, Agrappi C, Manco MT, Cerulli T, Clerici P. Implementation of screening for Toxoplasma gondii infection in pregnancy. J Clin Med Res. 2010;2(3):112–116. doi:10.4021/jocmr2010.05.321w
   PubMedGoogle Scholar
• Röser D, Nielsen HV, Petersen E, Saugmann‐Jensen P, Nørgaard‐Pedersen PB. Congenital toxoplasmosis—a report on the Danish neonatal screening programme 1999–2007. J Inherit Metab Dis. 2010;33:241–247. doi:10.1007/s10545-010-9124-4
   Web of Science ®Google Scholar
• Picone O, Fuchs F, Benoist G, et al. Toxoplasmosis screening during pregnancy in France: opinion of an expert panel for the CNGOF. J Gynecol Obstet Hum. 2020;49(7):101814. doi:10.1016/j.jogoh.2020.101814
   Web of Science ®Google Scholar
• Gilbert R, Peckham C. Congenital toxoplasmosis in the United Kingdom: to screen or not to screen? J Med Screen. 2002;9(3):135–141. doi:10.1136/jms.9.3.135
   PubMed Web of Science ®Google Scholar